UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A review and evaluation of the state-of-the-art in PV solar power forecasting: Techniques and optimization

Renewable & sustainable energy reviews, 2020-05, Vol.124, p.109792, Article 109792

2020

Volltextzugriff (PDF)

Multiple sclerosis: risk factors, prodromes, and potential causal pathways

Lancet neurology, 2010-07, Vol.9 (7), p.727-739

2010

Volltextzugriff (PDF)

An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis

PloS one, 2010-09, Vol.5 (9), p.e12496

2010

Volltextzugriff (PDF)

Can real-world data really replace randomised clinical trials?

BMC medicine, 2020-01, Vol.18 (1), p.13-13, Article 13

2020

Volltextzugriff (PDF)

Smoking and multiple sclerosis: an updated meta-analysis

PloS one, 2011-01, Vol.6 (1), p.e16149-e16149

2011

Volltextzugriff (PDF)

The Blurred Lines of HTA Agency Decision Making

Medical decision making, 2024-01, Vol.44 (1), p.3-4

2024

Volltextzugriff (PDF)

Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer

Nature communications, 2022-06, Vol.13 (1), p.3500-3500, Article 3500

2022

Volltextzugriff (PDF)

Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB11501 is regulated by vitamin D

PLoS genetics, 2009-02, Vol.5 (2), p.e1000369-e1000369

2009

Volltextzugriff (PDF)

Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants

Journal of comparative effectiveness research, 2020-06, Vol.9 (9), p.603-614

2020

Volltextzugriff (PDF)

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 12

Journal of comparative effectiveness research, 2023-07, Vol.12 (7), p.e230092-e230092

2023

Volltextzugriff (PDF)

Month of birth, vitamin D and risk of immune-mediated disease: a case control study

BMC medicine, 2012-07, Vol.10 (1), p.69-69, Article 69

2012

Volltextzugriff (PDF)

Low embodied energy cement stabilised rammed earth building—A case study

Energy and buildings, 2014-01, Vol.68, p.541-546

2014

Volltextzugriff (PDF)

Synthesis of chiral functional polyhydroxylated arenes via Mukaiyama aldol reaction from Perlin aldehydes

Carbohydrate research, 2024-01, Vol.535, p.109004-109004, Article 109004

2024

Volltextzugriff (PDF)

Assessment of tumour-agnostic therapies in basket trials

The lancet oncology, 2022-01, Vol.23 (1), p.e7-e7

2022

Volltextzugriff (PDF)

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10

Journal of comparative effectiveness research, 2023-01, Vol.12 (1), p.e220194-e220194

2023

Volltextzugriff (PDF)

Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study

BMC medicine, 2011-01, Vol.9 (1), p.1-1, Article 1

2011

Volltextzugriff (PDF)

Prodromal symptoms of multiple sclerosis in primary care

Annals of neurology, 2018-06, Vol.83 (6), p.1162-1173

2018

Volltextzugriff (PDF)

Meta-analysis of the relationship between multiple sclerosis and migraine

PloS one, 2012-09, Vol.7 (9), p.e45295-e45295

2012

Volltextzugriff (PDF)

Access in all areas? A round up of developments in market access and health technology assessment: part 3

Journal of comparative effectiveness research, 2024-03, Vol.13 (3), p.e240009-e240009

2024

Volltextzugriff (PDF)

Epidemiology of Multiple Sclerosis

Neurologic clinics, 2011-05, Vol.29 (2), p.207-217

2011

Volltextzugriff (PDF)

Sex ratio of multiple sclerosis in Canada: a longitudinal study

Lancet neurology, 2006-11, Vol.5 (11), p.932-936

2006

Volltextzugriff (PDF)

Is the price right? Paying for value today to get more value tomorrow

BMC medicine, 2024-01, Vol.22 (1), p.45-45, Article 45

2024

Volltextzugriff (PDF)

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 8

Journal of comparative effectiveness research, 2022-09, Vol.11 (13), p.915-917

2022

Volltextzugriff (PDF)

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 9

Journal of comparative effectiveness research, 2022-11, Vol.11 (16), p.1147-1149

2022

Volltextzugriff (PDF)

A comparative study of CSF neurofilament light and heavy chain protein in MS

Multiple sclerosis, 2013-10, Vol.19 (12), p.1597-1603

2013

Volltextzugriff (PDF)

1 – 25 von 755

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(559)
Mit Volltextzugriff
(645)

Publikationsform

Sprache

Englisch
(755)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(533)
Humans
(297)
Life Sciences & Biomedicine
(244)
Female
(170)
Male
(158)
Technology
(150)
Multiple Sclerosis
(140)
Science & Technology - Other Topics
(140)
Multidisciplinary Sciences
(137)
Risk Factors
(110)
Adult
(103)
Engineering
(100)
Medicine And Health Sciences
(99)
Patients
(91)
Neurology
(89)
Neurosciences & Neurology
(87)
Engineering, Electrical & Electronic
(85)
Clinical Neurology
(78)
Biology And Life Sciences
(72)
Automation & Control Systems
(70)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(140)
Journal Of Comparative Effectiveness Research
(34)
Multiple Sclerosis
(18)
Ieee Transactions On Automatic Control
(13)
F1000 Research
(12)
F1000research
(12)
Bmc Medicine
(9)
Journal Of Neurology
(9)
Electronics Letters
(8)
Human Molecular Genetics
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

A review and evaluation of the state-of-the-art in PV solar power forecasting: Techniques and optimization

Multiple sclerosis: risk factors, prodromes, and potential causal pathways

An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis

Can real-world data really replace randomised clinical trials?

Smoking and multiple sclerosis: an updated meta-analysis

The Blurred Lines of HTA Agency Decision Making

Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer

Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB11501 is regulated by vitamin D

Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 12

Month of birth, vitamin D and risk of immune-mediated disease: a case control study

Low embodied energy cement stabilised rammed earth building—A case study

Synthesis of chiral functional polyhydroxylated arenes via Mukaiyama aldol reaction from Perlin aldehydes

Assessment of tumour-agnostic therapies in basket trials

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10

Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study

Prodromal symptoms of multiple sclerosis in primary care

Meta-analysis of the relationship between multiple sclerosis and migraine

Access in all areas? A round up of developments in market access and health technology assessment: part 3

Epidemiology of Multiple Sclerosis

Sex ratio of multiple sclerosis in Canada: a longitudinal study

Is the price right? Paying for value today to get more value tomorrow

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 8

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 9

A comparative study of CSF neurofilament light and heavy chain protein in MS

Suchergebnisse filtern